Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.

Hatzichristou, D; Haro, J M; Martin-Morales, A; von Keitz, A; Riley, A; Bertsch, J; Belger, M; Wolka, A M; Beardsworth, A

Hatzichristou, D; Haro, J M; Martin-Morales, A; von Keitz, A; Riley, A; Bertsch, J; Belger, M; Wolka, A M; Beardsworth, A.

Affiliation

Hatzichristou D; 2nd Department of Urology, Papageorgiou General Hospital and Center for Sexual and Reproductive Health, Aristotle University of Thessaloniki, Thessaloniki, Greece. hatzichr@med.auth.gr

Int J Clin Pract ; 61(11): 1850-62, 2007 Nov.

Article in En | MEDLINE | ID: mdl-17850306

Subject(s)

Carbolines/therapeutic use; Erectile Dysfunction/drug therapy; Imidazoles/therapeutic use; Patient Satisfaction; Phosphodiesterase Inhibitors/therapeutic use; Piperazines/therapeutic use; Sulfones/therapeutic use; Adolescent; Adult; Aged; Cohort Studies; Follow-Up Studies; Humans; Male; Middle Aged; Patient Compliance; Prospective Studies; Purines/therapeutic use; Regression Analysis; Severity of Illness Index; Sildenafil Citrate; Surveys and Questionnaires; Tadalafil; Time Factors; Treatment Outcome; Triazines/therapeutic use; Vardenafil Dihydrochloride

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phosphodiesterase Inhibitors / Piperazines / Sulfones / Carbolines / Patient Satisfaction / Imidazoles / Erectile Dysfunction Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Humans / Male / Middle aged Language: En Journal: Int J Clin Pract Year: 2007 Document type: Article

Search on Google

XML

PubMed Links